SCHEMBL6038534

SCHEMBL6038534

COc1ccc(N=O)c(C=O)c1OC

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 5/20 0.41
ALDH1A1 P00352 6/20 0.39
TSHR P16473 1/20 0.39
CYP1A2 P05177 2/20 0.37
ABCG2 Q9UNQ0 1/20 0.37
CYP1A1 P04798 1/20 0.37
CYP1B1 Q16678 1/20 0.37
MAPT P10636 3/20 0.36
AOX1 Q06278 1/20 0.36
NFE2L2 Q16236 1/20 0.36
KDM4E B2RXH2 2/20 0.36
LMNA P02545 2/20 0.36
HPGD P15428 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
BRS3 P32247 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CYP19A1 P11511 1/20 0.35
POLB P06746 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1001988 0.81 ERN1 (0.48) ERN1ALDH1A1TSHRCYP1A2ABCG2
SCHEMBL29459689 0.81 ERN1 (0.48) ERN1ALDH1A1TSHRCYP1A2ABCG2
SCHEMBL4039891 0.76 ERN1 (0.44) ERN1ALDH1A1TSHRCYP1A2ABCG2
SCHEMBL30681224 0.76 ALDH1A1 (0.48) ERN1ALDH1A1TSHRCYP1A2ABCG2
SCHEMBL10923461 0.76 ERN1 (0.53) ERN1ALDH1A1ABCG2MAPTAOX1
SCHEMBL4374159 0.74 ERN1 (0.66) ERN1ALDH1A1TSHRCYP1A2ABCG2
SCHEMBL453409 0.74 ERN1 (0.43) ERN1ALDH1A1TSHRCYP1A2ABCG2
SCHEMBL31663469 0.74 ERN1 (0.66) ERN1ALDH1A1TSHRCYP1A2ABCG2
SCHEMBL31813608 0.74 ERN1 (0.43) ERN1ALDH1A1TSHRCYP1A2ABCG2
SCHEMBL9246447 0.74 ALDH1A1 (0.43) ERN1ALDH1A1TSHRCYP1A2ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060210452-A1 Very large scale immobilized polymer synthesis AFFYMAX TECHNOLOGIES, N.V., A NETHERLANDS ANTILLES CORPORATION 2006-09-21 US disclosed
US-20060194258-A1 Polypeptide array synthesis AFFYMETRIX, INC. (US) 2006-08-31 US disclosed
US-7087732-B2 Nucleotides and analogs having photoremovable protecting groups AFFYMETRIX, INC. (US) 2006-08-08 US disclosed
US-6955915-B2 Apparatus comprising polymers AFFYMETRIX, INC. (US) 2005-10-18 US disclosed
US-20050208537-A1 Very large scale immobilized polymer synthesis AFFYMETRIX, INC. (US) 2005-09-22 US disclosed
US-6919211-B1 Polypeptide arrays AFFYMETRIX, INC. (US) 2005-07-19 US disclosed
US-20050153362-A1 Polymer arrays PIRRUNG MICHAEL C (US) 2005-07-14 US disclosed
US-20050153363-A1 Polymer arrays PIRRUNG MICHAEL C (US) 2005-07-14 US disclosed
US-20050118706-A1 Polymer arrays AFFYMETRIX, INC. (US) 2005-06-02 US disclosed
US-20050095652-A1 Apparatus comprising polymers AFFYMETRIX, INC. (US) 2005-05-05 US disclosed
US-6124102-A EVALUATING THE BINDING OF COMPOUNDS TO BINDING PROTEINS; INCUBATION OF LABELLED BINDING PROTEIN TO SUBSTRATE, ANALYZE PIXEL INTENSITY AT KNOWN POSITIONS, USE COMPUTER TO ANALYZE RELATIVE BINDING OF COMPOUNDS TO BINDING PROTEIN AFFYMETRIX, INC. (US) 2000-09-26 US disclosed
US-5889165-A Photolabile nucleoside protecting groups AFFYMETRIX, INC. (US) 1999-03-30 US disclosed
US-5753788-A Photolabile nucleoside protecting groups AFFYMETRIX, INC. (US) 1998-05-19 US disclosed
US-5744101-A Photolabile nucleoside protecting groups AFFYMAX TECHNOLOGIES N.V. (GB) 1998-04-28 US disclosed
US-5744305-A Arrays of materials attached to a substrate AFFYMETRIX, INC. (US) 1998-04-28 US disclosed
US-5489678-A 6-NITRO-1,3-BENZOXAZOL-5-YL ALKYLOXY PROTECTIVE GROUP ON THE 5' POSITION OF A DEOXYNUCLEOSIDE; COMPUTERIZED SOLID PHASE SYNTHESIS AFFYMAX TECHNOLOGIES N.V. (NL) 1996-02-06 US disclosed
US-5424186-A Biosynthesis of oligonucleotides on solid substrate by irradiation of predefined segments to remove blocking agents; then coupling with nucleotide AFFYMAX TECHNOLOGIES N.V. (AN) 1995-06-13 US disclosed
EP-0562025-A4 1994-03-30 EP disclosed
EP-0562025-A1 VERY LARGE SCALE IMMOBILIZED POLYMER SYNTHESIS AFFYMAX TECHNOLOGIES N.V. (AN) 1993-09-29 EP disclosed
WO-1992010092-A1 VERY LARGE SCALE IMMOBILIZED POLYMER SYNTHESIS AFFYMAX TECHNOLOGIES N.V. (AN) 1992-06-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194258-A1 Polypeptide array synthesis MRPL21, NGLY1, PSAP ERN1 881/4885ALDH1A1 4233/4885TSHR 2311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.